{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:56Z","timestamp":1786116776592,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.05.008","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T20:18:45Z","timestamp":1783369125000},"page":"617-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Principles of Pharmacokinetics During Pregnancy in Women and Their Fetuses\u2014An Update"],"prefix":"10.1016","volume":"53","author":[{"given":"Andr\u00e9","family":"Dallmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clp.2026.05.008_bib1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/0002-9378(71)90809-X","article-title":"Placental transfer and neonatal elimination of diphenylhydantoin","volume":"109","author":"Mirkin","year":"1971","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2026.05.008_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00000542-197508000-00004","article-title":"Perinatal pharmacology: placental transfer, fetal localization, and neonatal disposition of drugs","volume":"43","author":"Mirkin","year":"1975","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clp.2026.05.008_bib3","series-title":"Drug treatment","first-page":"76","article-title":"Fetal clinical pharmacology","author":"Ward","year":"1980"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.siny.2012.11.002","article-title":"Perinatal pharmacology","volume":"18","author":"van den Anker","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.clp.2026.05.008_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.clp.2019.02.014","article-title":"Principles of pharmacokinetics in the pregnant woman and fetus","volume":"46","author":"Ward","year":"2019","journal-title":"Clin Perinatol"},{"issue":"6","key":"10.1016\/j.clp.2026.05.008_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ajog.2022.07.054","article-title":"Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical length >25 mm","volume":"227","author":"Conde-Agudelo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib7","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.04.012","article-title":"Society for Maternal-Fetal Medicine Statement: response to the Food and Drug Administration\u2019s withdrawal of 17-alpha hydroxyprogesterone caproate","volume":"229","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.008_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.733520","article-title":"Mechanistic coupling of a novel in silico cotyledon perfusion model and a physiologically based pharmacokinetic model to predict fetal acetaminophen pharmacokinetics at delivery","volume":"9","author":"Mian","year":"2021","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.clp.2026.05.008_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jcph.1515","article-title":"Physiologically based pharmacokinetic models to predict maternal pharmacokinetics and fetal exposure to emtricitabine and acyclovir","volume":"60","author":"Liu","year":"2020","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40262-023-01323-6","article-title":"Development of a generic fetal physiologically based pharmacokinetic model and prediction of human maternal and fetal organ concentrations of cefuroxime","volume":"63","author":"Liu","year":"2024","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2026.05.008_bib11","first-page":"S94","article-title":"Predicting human fetal drug exposure through maternal-fetal PBPK modeling and in vitro or ex ivvo studies","volume":"62","author":"Balhara","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clp.2026.05.008_bib12","first-page":"1106","article-title":"A study of the German outbreak of phocomelia. The thalidomide syndrome","volume":"180","author":"Taussig","year":"1962","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.05.008_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/scientificamerican0862-29","article-title":"The thalidomide syndrome","volume":"207","author":"Taussig","year":"1962","journal-title":"Sci Am"},{"issue":"7256","key":"10.1016\/j.clp.2026.05.008_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(62)90462-2","article-title":"Thalidomide and limb deformities","volume":"2","author":"Millen","year":"1962","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib16","first-page":"12","article-title":"Maternal drug therapy for fetal disorders","volume":"16","author":"Ward","year":"1992","journal-title":"Semin Perinatol"},{"issue":"6","key":"10.1016\/j.clp.2026.05.008_bib17","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0735-1097(86)80318-7","article-title":"Diagnosis of fetal arrhythmias using echocardiographic and Doppler techniques","volume":"8","author":"Steinfeld","year":"1986","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.clp.2026.05.008_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007164","article-title":"First-line antiarrhythmic transplacental treatment for fetal tachyarrhythmia: a systematic review and meta-analysis","volume":"6","author":"Alsaied","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.clp.2026.05.008_bib19","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/j.hrthm.2023.05.017","article-title":"HRS expert consensus statement on the management of arrhythmias during pregnancy","volume":"20","author":"Joglar","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.clp.2026.05.008_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1749-6632.2009.05225.x","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a paradigm for prenatal diagnosis and treatment","volume":"1192","author":"Nimkarn","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.clp.2026.05.008_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0095-5108(18)30330-0","article-title":"Pharmacologic enhancement of fetal lung maturation","volume":"21","author":"Ward","year":"1994","journal-title":"Clin Perinatol"},{"issue":"3","key":"10.1016\/j.clp.2026.05.008_bib22","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/v15040849","article-title":"Prevention of the vertical transmission of HIV; A recap of the journey so far","volume":"15","author":"Cardenas","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib24","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1067\/mob.2001.117353","article-title":"Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus","volume":"185","author":"Johnson","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0029-7844(97)00587-5","article-title":"Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus","volume":"91","author":"de Cueto","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.008_bib26","series-title":"The fundamentals of pediatric drug dosing","first-page":"127","article-title":"Perinatal pharmacology and maternal\/fetal dosing","author":"Mahmood","year":"2016"},{"issue":"11","key":"10.1016\/j.clp.2026.05.008_bib27","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/psp4.13218","article-title":"Enhancing inclusivity in clinical trials: model-informed drug development for pregnant individuals in the era of personalized medicine","volume":"13","author":"Dallmann","year":"2024","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10928-020-09677-1","article-title":"Anatomical and physiological alterations of pregnancy","volume":"47","author":"Kazma","year":"2020","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"10.1016\/j.clp.2026.05.008_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2174\/1381612825666190319102812","article-title":"Methodological approaches to evaluate fetal drug exposure","volume":"25","author":"Bouazza","year":"2019","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.clp.2026.05.008_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3390\/pharmaceutics16030375","article-title":"Forecasting fetal buprenorphine exposure through maternal-fetal physiologically based pharmacokinetic modeling","volume":"16","author":"van Hoogdalem","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bcp.12815","article-title":"Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models","volume":"81","author":"De Sousa Mendes","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.clp.2026.05.008_bib32","doi-asserted-by":"crossref","first-page":"228.e1","DOI":"10.1016\/j.ajog.2024.05.012","article-title":"Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach","volume":"232","author":"Van Der Heijden","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.clp.2026.05.008_bib33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/dmd.121.000538","article-title":"Successful prediction of human fetal exposure to P-Glycoprotein substrate drugs using the proteomics-informed relative expression factor approach and PBPK modeling and simulation","volume":"49","author":"Anoshchenko","year":"2021","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0735-1097(03)00779-4","article-title":"Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics","volume":"42","author":"Oudijk","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib35","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/bcp.15589","article-title":"Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically-based pharmacokinetic modelling approach","volume":"89","author":"Li","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/dmd.121.000711","article-title":"Prediction of maternal and fetoplacental concentrations of ecfazolin, cefuroxime, and amoxicillin during pregnancy using bottom-up physiologically based pharmacokinetic models","volume":"50","author":"Abduljalil","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.clp.2026.05.008_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/psp4.13013","article-title":"Development and application of a PBPK modeling strategy to support antimalarial drug development","volume":"12","author":"Abla","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"8","key":"10.1016\/j.clp.2026.05.008_bib38","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s40262-022-01127-0","article-title":"Prediction of maternal and fetal doravirine exposure by integrating physiologically based pharmacokinetic modeling and human placenta perfusion experiments","volume":"61","author":"Bukkems","year":"2022","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2026.05.008_bib39","first-page":"S81","article-title":"Mechanistic modeling of the drug-drug interaction between efavirenz and dolutegravir: is this interaction clinically relevant when switching from efavirenz to dolutegravir during pregnancy?","volume":"63","author":"Dallmann","year":"2023","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib40","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/bcp.16006","article-title":"Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy","volume":"91","author":"Atoyebi","year":"2025","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.clp.2026.05.008_bib41","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jcph.2404","article-title":"Mechanistic framework to predict maternal-placental-fetal pharmacokinetics of nifedipine employing physiologically based pharmacokinetic modeling approach","volume":"64","author":"Werdan Romao","year":"2024","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.clp.2026.05.008_bib42","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/jcph.2496","article-title":"Labetalol dosing in pregnancy: PBPK\/PD and CYP2C19 polymorphisms","volume":"64","author":"Liu","year":"2024","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clp.2026.05.008_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106707","article-title":"Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy","volume":"194","author":"Chen","year":"2024","journal-title":"Eur J Pharmaceut Sci"},{"issue":"5","key":"10.1016\/j.clp.2026.05.008_bib44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/psp4.70007","article-title":"Toward precision dosing of lamotrigine during pregnancy: physiologically based pharmacokinetic modeling and simulation","volume":"14","author":"Qian","year":"2025","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"12","key":"10.1016\/j.clp.2026.05.008_bib45","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s40262-025-01574-5","article-title":"Prediction of maternal and fetal exposure to escitalopram, sertraline, and paroxetine by combining human ex vivo placenta perfusion data and physiologically based pharmacokinetic modeling","volume":"64","author":"Preta","year":"2025","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.clp.2026.05.008_bib46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jpp\/rgad106","article-title":"Precision dosing of venlafaxine during pregnancy: a pharmacokinetics modelling approach","volume":"76","author":"Alenezi","year":"2024","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.clp.2026.05.008_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.733823","article-title":"Maternal-fetal pharmacology of drugs: a review of current status of the application of physiologically based pharmacokinetic models","volume":"9","author":"Chaphekar","year":"2021","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41540-020-00157-3","article-title":"Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy","volume":"6","author":"George","year":"2020","journal-title":"npj Syst Biol Appl"},{"issue":"5","key":"10.1016\/j.clp.2026.05.008_bib49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-199528050-00001","article-title":"Pharmacological treatment of the fetus. Clinical pharmacokinetic considerations","volume":"28","author":"Ward","year":"1995","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib50","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1677\/joe.0.0450515","article-title":"Premature delivery of foetal lambs infused with glucocorticoids","volume":"45","author":"Liggins","year":"1969","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.clp.2026.05.008_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1677\/joe.0.0420323","article-title":"Premature parturition after infusion of corticotrophin or cortisol into foetal lambs","volume":"42","author":"Liggins","year":"1968","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1542\/peds.47.4.650","article-title":"Adrenal gland structure and the development of hyaline membrane disease","volume":"47","author":"Naeye","year":"1971","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.clp.2026.05.008_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2265.1997.1230939.x","article-title":"Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure","volume":"46","author":"Benediktsson","year":"1997","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.008_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib55","first-page":"135","article-title":"Antenatal steroids and neonatal periventricular leukomalacia","volume":"97","author":"Canterino","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.008_bib56","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.05.008_bib57","first-page":"144","article-title":"Repeat courses - National Institutes of Health Consensus Development Conference Statement. August 17-18, 2000","volume":"98","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2026.05.008_bib58","doi-asserted-by":"crossref","first-page":"132.e1","DOI":"10.1016\/j.ajog.2017.11.560","article-title":"Low-dose betamethasone-acetate for fetal lung maturation in preterm sheep","volume":"218","author":"Schmidt","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2026.05.008_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41390-020-01249-w","article-title":"Antenatal corticosteroids: a reappraisal of the drug formulation and dose","volume":"89","author":"Jobe","year":"2021","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1016\/j.clp.2026.05.008_bib60","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/cpt.1084","article-title":"Physiologically based pharmacokinetic modeling in pregnancy: a systematic review of published models","volume":"104","author":"Dallmann","year":"2018","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:15:31Z","timestamp":1786018531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510826000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095510826000564"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.008","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Principles of Pharmacokinetics During Pregnancy in Women and Their Fetuses\u2014An Update","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}